New study tests safer way to zap knee pain without surgery
NCT ID NCT07475793
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial tests whether using ultrasound to guide a nerve-freezing procedure (radiofrequency ablation) is better than the standard X-ray-guided method for people with chronic knee osteoarthritis. Fifty-two adults over 50 with severe knee pain will be randomly assigned to one of the two methods. The goal is to see which approach provides greater pain relief and improved function over six months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
radiofrequency ablation
What this could lead to
If successful, this could show that ultrasound guidance is a better, safer way to perform nerve ablation for lasting knee pain relief.
What could go wrong
This is a small, early-stage trial with only 52 people. The pain relief is temporary (3-12 months) and the procedure may not work for everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KNEE OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••